Litigation Details for Acuitas Therapeutics Inc. v. Genevant Sciences GmbH (S.D.N.Y. 2022)
✉ Email this page to a colleague
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH (S.D.N.Y. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-03-18 |
| Court | District Court, S.D. New York | Date Terminated | 2023-08-07 |
| Cause | 28:2201dj Declaratory Judgment | Assigned To | Mary Kay Vyskocil |
| Jury Demand | None | Referred To | |
| Patents | 8,058,069; 8,492,359; 8,822,668; 9,364,435 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Acuitas Therapeutics Inc. v. Genevant Sciences GmbH
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Acuitas Therapeutics Inc. v. Genevant Sciences GmbH (S.D.N.Y. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-03-18 | 1 | Complaint | Therapeutics Inc.. (Attachments: # 1 Exhibit A-US 8,058,069, # 2 Exhibit B-US 8,492,359, # 3 Exhibit C-US …2022 7 August 2023 1:22-cv-02229 830 Patent None District Court, S.D. New York | External link to document |
| 2022-09-06 | 42 | Amended Complaint | Exhibit A-US Patent No. 8,058,069, # 3 Exhibit B-US Patent No. 8,492,359, # 4 Exhibit C-US Patent No. 8,822,668…Exhibit D-US Patent No. 9,006,417, # 6 Exhibit E-US Patent No. 9,364,435, # 7 Exhibit F-US Patent No. 9,404,127…Exhibit G-US Patent No. 9,504,651, # 9 Exhibit H-US Patent No. 9,518,272, # 10 Exhibit I-US Patent No. 11,141,378…2022 7 August 2023 1:22-cv-02229 830 Patent None District Court, S.D. New York | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
